Emerging approaches of transcatheter valve repair/insertion

Maurizio Taramasso, Micaela Cioni, Andrea Giacomini, Iassen Michev, Cosmo Godino, Matteo Montorfano, Antonio Colombo, Ottavio Alfieri, Francesco Maisano, Maurizio Taramasso, Micaela Cioni, Andrea Giacomini, Iassen Michev, Cosmo Godino, Matteo Montorfano, Antonio Colombo, Ottavio Alfieri, Francesco Maisano

Abstract

Aortic stenosis (AS) and mitral regurgitation (MR) account for the majority of valvular diseases and their prevalence is increasing according to increased life expectancy. Surgical treatment is the gold standard, although operative risk may be high in some patients due to comorbidities and age. A large part of the patients at high surgical risk who could beneficiate of treatment are not referred to surgery. Therefore, there is a need of alternative and less invasive procedures.

Figures

Figure 1
Figure 1
The Edwards-Sapien balloon-expandable prosthetic valve, constructed of a stainless-steel stent, bovine pericardial leaflets and a fabric sealing cuff.
Figure 2
Figure 2
The CoreValve self-expandable prosthetic valve, constructed of a nitinol stent, pericardial leaflets, and sealing cuff.
Figure 3
Figure 3
The Mitraclip device is a two-armed, polyester-covered, fixation device. Each arm has an opposing gripper that aids the leaflets in the clip by means of multipronged friction element.
Figure 4
Figure 4
Anatomical exclusion criteria for the percutaneous edge-to-edge repair.

References

    1. Vahanian A, Baumgartner H, Bax J, et al. Task force on the management of valvular hearth disease of the European Society of Cardiology; ESC committee for practice guidelines. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. European Heart Journal. 2007;28:230–268.
    1. Bonow RO, Carabello BA, Chatterjee K, et al. 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–e661.
    1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe. The Euro Heart Survey on valvular heart disease. European Heart Journal. 2003;24(13):1231–1243.
    1. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? European Heart Journal. 2007;28(11):1358–1365.
    1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011.
    1. US Census Bureau. United States Census 2000. US Census Bureau: Washington, DC, USA; 2001.
    1. Culliford AT, Galloway AC, Colvin SB, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. American Journal of Cardiology. 1991;67(15):1256–1260.
    1. Kvidal P, Bergstrom R, Horte L-G, Stahle E. Observed and relative survival after aortic valve replacement. Journal of the American College of Cardiology. 2000;35(3):747–756.
    1. Connolly HM, Oh JK, Schaff HV, et al. Severe aortic stenosis with low transvalvular gradient and severe left: ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation. 2000;101(16):1940–1946.
    1. Sedrakyan A, Hebert P, Vaccarino V, et al. Quality of life after aortic valve replacement with tissue and mechanical implants. Journal of Thoracic and Cardiovascular Surgery. 2004;128(2):266–272.
    1. Huber CH, Goeber V, Berdat P, Carrel T, Eckstein F. Benefits of cardiac surgery in octogenarians—a postoperative quality of life assessment. European Journal of Cardio-Thoracic Surgery. 2007;31(6):1099–1105.
    1. Vicchio M, Della Corte A, De Santo LS, et al. Tissue versus mechanical prostheses: quality of life in octogenarians. Annals of Thoracic Surgery. 2008;85(4):1290–1295.
    1. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: results from a nationally representative database. Annals of Thoracic Surgery. 2000;70(6):1939–1945.
    1. Burr LH, Jamieson WRE, Munro AI, Miyagishima RT, Germann E. Porcine bioprostheses in the elderly: clinical performance by age groups and valve positions. Annals of Thoracic Surgery. 1995;60(2):S264–S269.
    1. Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE. European Heart Journal. 2003;24(9):881–882.
    1. Edwards FH, Grover FL, Shroyer ALW, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Annals of Thoracic Surgery. 1997;63(3):903–908.
    1. Walther T, Falk V, Dewey T, et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. Journal of the American College of Cardiology. 2007;50(1):56–60.
    1. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the CoreValve revalving system. Catheterization and Cardiovascular Interventions. 2007;70(5):760–764.
    1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008.
    1. Vahanian A, Alfieri OR, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) European Journal of Cardio-Thoracic Surgery. 2008;34(1):1–8.
    1. Tops LF, Kapadia SR, Tuzcu EM, et al. Percutaneous valve procedures: an update. Current Problems in Cardiology. 2008;33(8):417–457.
    1. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. Journal of the American College of Cardiology. 2004;43(4):698–703.
    1. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113(6):842–850.
    1. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. Journal of the American College of Cardiology. 2007;50(1):69–76.
    1. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(7):755–763.
    1. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Journal of the American College of Cardiology. 2006;47(6):1214–1223.
    1. De Jaegere P, Van Dijk LC, Laborde JC, et al. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access. Prostar XL and TandemHeart. Eurointervention. 2007;2:500–505.
    1. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114(6):591–596.
    1. Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation—proof of concept. European Journal of Cardio-Thoracic Surgery. 2007;31(1):9–15.
    1. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116(11):I240–I245.
    1. Fraccaro C, Napodano M, Tarantini G, et al. Expanding the eligibility for transcatheter aortic valve implantation. The trans-subclavian retrograde approach using the III generation CoreValve revalving system. Journal of the American College of Cardiology. 2009;2(9):828–833.
    1. Sharp ASP, Michev I, Colombo A. First trans-axillary implantation of Edwards Sapien valve to treat an incompetent aortic bioprosthesis. Catheterization and Cardiovascular Interventions. 2010;75(4):507–510.
    1. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheterization and Cardiovascular Interventions. 2010;75(7):1129–1136.
    1. Bauernschmitt R, Schreiber C, Bleiziffer S, et al. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. The Heart Surgery Forum. 2009;12(1):E63–E64.
    1. Roques F, Nashef SAM, Michel P. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. Journal of Heart Valve Disease. 2001;10(5):572–578.
    1. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography. Implications for transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2008;1(3):321–330.
    1. Moss RR, Ivens E, Pasupati S, et al. Role of echocardiography in percutaneous aortic valve implantation. Journal of the American College of Cardiology. 2008;1(1):15–24.
    1. Wood DA, Tops LF, Mayo JR, et al. Role of multislice computed tomography in transcatheter aortic valve replacement. American Journal of Cardiology. 2009;103(9):1295–1301.
    1. Akhtar M, Tuzcu EM, Kapadia SR, et al. Aortic root morphology in patients undergoing percutaneous aortic valve replacement. Evidence of aortic root remodeling. Journal of Thoracic and Cardiovascular Surgery. 2009;137(4):950–956.
    1. Stolzmann P, Knight J, Desbiolles L, et al. Remodelling of the aortic root in severe tricuspid aortic stenosis: implications for transcatheter aortic valve implantation. European Radiology. 2009;19(6):1316–1323.
    1. Kurra V, Schoenhagen P, Roselli EE, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. Journal of Thoracic and Cardiovascular Surgery. 2009;137(5):1258–1264.
    1. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89(2):642–650.
    1. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving systemml: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4(2):242–249.
    1. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. Acute and late outcomes of the multicenter Canadian experience. Journal of the American College of Cardiology. 2010;55(11):1080–1090.
    1. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114(15):1616–1624.
    1. Thomas M. 30 day results of the SOURCE registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIENTM valve. In: Proceedings of the EuroPCR; May 2009; Barcelona, Spain.
    1. Wendler O, Walther T, Nataf P. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. European Journal of Cardio-Thoracic Surgery.
    1. Flecher EM, Curry JW, Joudinaud TM, Kegel CL, Weber PA, Duran CMG. Coronary flow obstruction in percutaneous aortic valve replacement. An in vitro study. European Journal of Cardio-Thoracic Surgery. 2007;32(2):291–294.
    1. Chiam PTL, Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology. American Heart Journal. 2009;157(2):229–242.
    1. Limongelli G, Ducceschi V, D’Andrea A, et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart. 2003;89(8):901–904.
    1. El-Khally Z, Thibault B, Staniloae C, et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. American Journal of Cardiology. 2004;94(8):1008–1011.
    1. Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. Journal of the American College of Cardiology. 2008;1(3):305–309.
    1. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. Journal of the American College of Cardiology. 2008;1(3):310–316.
    1. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. American Heart Journal. 2009;157(5):860–866.
    1. Quill JL, Hill AJ, Laske TG, Alfieri O, Iaizzo PA. Mitral leaflet anatomy revisited. Journal of Thoracic and Cardiovascular Surgery. 2009;137(5):1077–1081.
    1. Alfieri O, De Bonis M, Lapenna E, et al. "Edge-to-edge" repair for anterior mitral leaflet prolapse. Seminars in Thoracic and Cardiovascular Surgery. 2004;16(2):182–187.
    1. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. Journal of Thoracic and Cardiovascular Surgery. 2001;122(4):674–681.
    1. Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. European Journal of Cardio-thoracic Surgery. 1998;13(3):240–246.
    1. St. Goar FG, Fann JI, Komtebedde J, et al. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation. 2003;108(16):1990–1993.
    1. Ussia GP, Barbanti M, Tamburino C. Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip system using conscious sedation. Catheterization and Cardiovascular Interventions. 2010;75(7):1137–1140.
    1. Casserly IP, Kapadia SR. Advances in percutaneous valvular intervention. Expert Review of Cardiovascular Therapy. 2005;3(1):143–158.
    1. Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the evalve MitraClip: lessons learned from EVEREST I. Journal of the American Society of Echocardiography. 2007;20(10):1131–1140.
    1. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. Journal of the American College of Cardiology. 2005;46(11):2134–2140.
    1. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system. Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. Journal of the American College of Cardiology. 2009;54(8):686–694.
    1. Feldman T. Endovascular Valve Edge-to-Edge REpair Study (EVEREST II) Randomized Clinical Trial: Primary Safety and Efficacy Endpoints. Atlanta, Ga, USA: American College of Cardiology; 2010.
    1. Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation. 2006;113(6):851–855.
    1. Liddicoat JR, Mac Neill BD, Gillinov AM, et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheterization and Cardiovascular Interventions. 2003;60(3):410–416.
    1. Maniu CV, Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. Journal of the American College of Cardiology. 2004;44(8):1652–1661.
    1. Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device european union study. Circulation. 2009;120(4):326–333.
    1. Siminiak T, Hoppe UC, Schofer J, et al. Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial) American Journal of Cardiology. 2009;104(4):565–570.
    1. Fukamachi K, Inoue M, Popović ZB, et al. Off-pump mitral valve repair using the Coapsys device: a pilot study in a pacing-induced mitral regurgitation model. Annals of Thoracic Surgery. 2004;77(2):688–692.
    1. Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Annals of Thoracic Surgery. 2006;81(1):42–46.
    1. Grossi EA, Saunders PC, Woo YJ, et al. Intraoperative effects of the Coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Annals of Thoracic Surgery. 2005;80(5):1706–1711.
    1. Pedersen WR, Block P, Leon M, et al. iCoapsys mitral valve repair systemml: percutaneous implantation in an animal model. Catheterization and Cardiovascular Interventions. 2008;72(1):125–131.
    1. Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheterization and Cardiovascular Interventions. 2006;68(4):528–533.
    1. Aranzulla TC, Cosgrave J, La Canna G, et al. Percutaneous treatment of periprosthetic mitral valve leaks: is it just a futile exercise? Annals of Thoracic Surgery. 2008;86(3):996–998.
    1. Kim MS, Casserly IP, Garcia JA, Klein AJ, Salcedo EE, Carroll JD. Percutaneous transcatheter closure of prosthetic mitral paravalvular leaks. Are we there yet? Journal of the American College of Cardiology. 2009;2(2):81–90.
    1. Bhudia SK, McCarthy PM, Smedira NG, Lam B-K, Rajeswaran J, Blackstone EH. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Annals of Thoracic Surgery. 2004;77(5):1598–1606.
    1. Kherani AR, Cheema FH, Casher J, et al. Edge-to-edge mitral valve repair: the Columbia Presbyterian experience. Annals of Thoracic Surgery. 2004;78(1):73–76.
    1. Maisano F, Caldarola A, Blasio A, et al. Midterm results of edge-to-edge mitral valve repair without annuloplasty. Journal of Thoracic and Cardiovascular Surgery. 2003;126(6):1987–1997.
    1. Privitera S, Butany J, Cusimano RJ, Silversides C, Ross H, Leask R. Images in cardiovascular medicine. Alfieri mitral valve repair: clinical outcome and pathology. Circulation. 2002;106(21):e173–e174.
    1. Fann JI, St. Goar FG, Komtebedde J, et al. Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation. 2004;110(8):988–993.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner